MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Autonomic Dysfunction in Parkinson’s Disease Link with disease severity and other non-motor signs

A. Mousli, R. Zouari, A. Rachdi, F. Nabli, D. Ben Mohamed, Z. Saeid, S. Ben Sassi (Ariana, Tunisia)

Meeting: 2024 International Congress

Abstract Number: 306

Keywords: Autonomic dysfunction, Parkinson’s

Category: Parkinson's Disease: Non-Motor Symptoms

Objective: Clarify the relationship between autonomic dysfunction, disease severity and NMS in PD patients.

Background: Parkinson’s disease (PD) is characterized by a combination of motor and non-motor symptoms (NMS). Autonomic symptoms (AS) are common NMS that can significantly impact the quality of life of PD patients and can occur during the early stage of PD.

Method: This retrospective study included patients from the department of neurology of the National Institute of Neurology Mongi Ben Hmida in Tunis, Tunisia, diagnosed with PD between 1980 and 2023. The diagnosis of PD was confirmed according to the Movement Disorder Society (MDS) diagnostic criteria of PD. The MDS Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) motor was used to estimate motor disability and Hoehn and Yahr (H&Y) stage was used to rate disease severity. The items 1.10, 1.11 et 1.12 from MDS-UPDRS part I, the items2.2, 2.3 from MDS-UPDRS part II and Scales for Outcomes in Parkinson’s Disease – Autonomic Dysfunction (SCOPA-AUT) were applied to evaluate AS in patients with PD.

Results: We included 150 patients (sex-ratio M/F=74/76) with a mean age of 64 years [28-96]. Thirty patients (20%) had a severe motor disorder (MDS-UPDRS> 59) and 11.3% of patients had a severe stage of the disease. One hundred and thirteen patients (75.3%) had motor complications (motor fluctuations and/or L-Dopa induced dyskinesia). The mean score of SCOPA-AUT was 23.19 [8-52]. Gastrointestinal, urinary, and cardiovascular dysfunction were reported respectively in 50.7%, 45.3% and 42%. Eight patients (5.3%) had fecal incontinence and 46 (30.7%) had urinary incontinence. Orthostatic hypotension was observed in 42%.

Constipation, urinary problems, and orthostatic hypotension were significantly correlated with severity of PD (p=0.0001, p=0.013 and p=0.007) and motor fluctuations (p=0.001, p=0.002 and p=0.001). Nevertheless, Neither L-Dopa induced dyskinesia nor levodopa dose was associated to AS (p=0.215 and p=0.106).

The SCOPA-AUT score was correlated with Epworth Sleepiness Scale, rapid-eye-movement sleep behavior disorder, sexual dysfunction, depression and cognitive impairment (p=0.0001).

Conclusion: AS are associated with significant morbidity and mortality. Our study demonstrates that AS increase with both the severity and the stage of PD and are significantly intrigued by other NMS.

To cite this abstract in AMA style:

A. Mousli, R. Zouari, A. Rachdi, F. Nabli, D. Ben Mohamed, Z. Saeid, S. Ben Sassi. Autonomic Dysfunction in Parkinson’s Disease Link with disease severity and other non-motor signs [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/autonomic-dysfunction-in-parkinsons-disease-link-with-disease-severity-and-other-non-motor-signs/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/autonomic-dysfunction-in-parkinsons-disease-link-with-disease-severity-and-other-non-motor-signs/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley